B.C.N.U. (1,3-bis (2-chloroethyl) -1-nitrosourea) in the treatment of advanced Hodgkin's disease.
D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D009603:Nitroso Compounds / Q000627:therapeutic use*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*
D009603:Nitroso Compounds; D009607:Nitrosourea Compounds; D014508:Urea